Cargando…

CXCR4(+) cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis

BACKGROUND: CXCR4, a transmembrane-receptor located on epithelial cells that is activated by CXCL12, may have a role in IPF via migration of CXCR4(+) fibrocytes to the lung. However, its expression has not been fully characterised in idiopathic pulmonary fibrosis (IPF) or other fibrotic interstitial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaffar, Jade, Griffiths, Kate, Oveissi, Sara, Duan, Mubing, Foley, Michael, Glaspole, Ian, Symons, Karen, Organ, Louise, Westall, Glen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449054/ https://www.ncbi.nlm.nih.gov/pubmed/32843095 http://dx.doi.org/10.1186/s12931-020-01467-0

Ejemplares similares

Matrix metalloproteinase-7 is increased in lung bases but not apices in idiopathic pulmonary fibrosis
por: Jaffar, Jade, et al.
Publicado: (2022)

Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis
por: Griffiths, K., et al.
Publicado: (2018)

Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis
por: Gaikwad, Archana Vijay, et al.
Publicado: (2023)

Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition
por: Gaikwad, Archana Vijay, et al.
Publicado: (2022)

Importance of Occupational Exposure Data: A National Idiopathic Pulmonary Fibrosis Registry Perspective
por: Teoh, Alan K. Y., et al.
Publicado: (2020)

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
por: Glaspole, Ian, et al.
Publicado: (2021)

Pulmonary rehabilitation for interstitial lung disease: Referral and patient experiences
por: Hoffman, Mariana, et al.
Publicado: (2021)

Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis
por: Cox, Ingrid A., et al.
Publicado: (2020)

Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis
por: Humphries, Stephen M., et al.
Publicado: (2022)

Oxygen therapy for interstitial lung disease: a systematic review
por: Bell, Emily C., et al.
Publicado: (2017)

Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
por: Bell, Emily C., et al.
Publicado: (2017)

Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections
por: Lu, Wenying, et al.
Publicado: (2022)

The fibrogenic actions of lung fibroblast-derived urokinase: a potential drug target in IPF
por: Schuliga, Michael, et al.
Publicado: (2017)

Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres
por: Jo, Helen E., et al.
Publicado: (2016)

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
por: Jo, Helen E., et al.
Publicado: (2018)

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
por: Organ, Louise A., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Casein Kinase 1δ/ε Inhibitor, PF670462 Attenuates the Fibrogenic Effects of Transforming Growth Factor-β in Pulmonary Fibrosis
por: Keenan, Christine R., et al.
Publicado: (2018)

A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis
por: Khoo, Jun Keng, et al.
Publicado: (2020)

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
por: Noble, Paul W., et al.
Publicado: (2016)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

Autophagy in Idiopathic Pulmonary Fibrosis
por: Patel, Avignat S., et al.
Publicado: (2012)

The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014)

Epidemiology of idiopathic pulmonary fibrosis
por: Ley, Brett, et al.
Publicado: (2013)

IPF - Idiopathic Pulmonary Fibrosis
Publicado: (2019)

Management of Idiopathic Pulmonary Fibrosis
por: Pleasants, Roy, et al.
Publicado: (2019)

Treatment of Idiopathic Pulmonary Fibrosis
por: Abuserewa, Sherif T, et al.
Publicado: (2021)

Cough in Idiopathic Pulmonary Fibrosis
por: Mann, Jennifer, et al.
Publicado: (2021)

Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016)

Idiopathic Pulmonary Fibrosis and Telomeres
por: Mulet, Alba, et al.
Publicado: (2022)

Living with idiopathic pulmonary fibrosis
por: Kirby, Tony
Publicado: (2021)

Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
por: Lancaster, Lisa, et al.
Publicado: (2016)

Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta, et al.
Publicado: (2015)

Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis
por: Duck, Annette, et al.
Publicado: (2015)

Global Gene Expression Analysis in an in vitro Fibroblast Model of Idiopathic Pulmonary Fibrosis Reveals Potential Role for CXCL14/CXCR4
por: Rodriguez, Luis R., et al.
Publicado: (2018)

PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
por: Oldham, Justin M., et al.
Publicado: (2023)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis
por: Organ, Louise, et al.
Publicado: (2015)

Role of Osteopontin in Idiopathic Pulmonary Fibrosis
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_3jde2kb32n02tbbidmsbcpjf7c